Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Morphea in adults and children cohort III: nested case-control study--the clinical significance of autoantibodies in morphea.

Dharamsi JW, Victor S, Aguwa N, Ahn C, Arnett F, Mayes MD, Jacobe H.

JAMA Dermatol. 2013 Oct;149(10):1159-65. doi: 10.1001/jamadermatol.2013.4207.

2.

Practice gaps: Evaluating the clinical utility of autoantibodies in morphea.

Chiu YE.

JAMA Dermatol. 2013 Oct;149(10):1166. doi: 10.1001/jamadermatol.2013.4908. No abstract available.

PMID:
23925297
3.

Antinuclear and anti-single-stranded DNA antibodies in morphea and generalized morphea.

Falanga V, Medsger TA Jr, Reichlin M.

Arch Dermatol. 1987 Mar;123(3):350-3.

PMID:
3545090
4.

Serum autoantibodies and their clinical associations in patients with childhood- and adult-onset linear scleroderma. A single-center study.

Arkachaisri T, Fertig N, Pino S, Medsger TA Jr.

J Rheumatol. 2008 Dec;35(12):2439-44. doi: 10.3899/jrheum.080098. Epub 2008 Nov 1.

PMID:
19004036
5.

Antigen specificity of antihistone antibodies in localized scleroderma.

Sato S, Fujimoto M, Ihn H, Kikuchi K, Takehara K.

Arch Dermatol. 1994 Oct;130(10):1273-7.

PMID:
7524451
7.

Antinuclear antibodies in children with localized scleroderma.

Rosenberg AM, Uziel Y, Krafchik BR, Hauta SA, Prokopchuk PA, Silverman ED, Laxer RM.

J Rheumatol. 1995 Dec;22(12):2337-43.

PMID:
8835572
8.

Frequency of antinuclear antibodies in mestizo Mexican children with morphea.

Guevara-Gutiérrez E, Yinh-Lao J, García-Gutiérrez P, Tlacuilo-Parra A.

Clin Rheumatol. 2010 Sep;29(9):1055-9. doi: 10.1007/s10067-010-1515-2. Epub 2010 Jun 14.

PMID:
20549277
9.

Clinical characteristics associated with antihistone antibodies in patients with localized scleroderma.

Sato S, Fujimoto M, Ihn H, Kikuchi K, Takehara K.

J Am Acad Dermatol. 1994 Oct;31(4):567-71.

PMID:
8089281
10.

Distinct autoimmune syndromes in morphea: a review of 245 adult and pediatric cases.

Leitenberger JJ, Cayce RL, Haley RW, Adams-Huet B, Bergstresser PR, Jacobe HT.

Arch Dermatol. 2009 May;145(5):545-50. doi: 10.1001/archdermatol.2009.79.

11.

Soluble CD4 and CD8 in serum from patients with localized scleroderma.

Sato S, Fujimoto M, Kikuchi K, Ihn H, Tamaki K, Takehara K.

Arch Dermatol Res. 1996 Jun;288(7):358-62.

PMID:
8818182
12.

Antihistone antibodies in scleroderma.

Parodi A, Drosera M, Barbieri L, Rebora A.

Dermatology. 1995;191(1):16-8.

PMID:
8589476
13.

Antihistone antibodies in patients with localized scleroderma.

Sato S, Ihn H, Soma Y, Igarashi A, Tamaki T, Kikuchi K, Ishibashi Y, Takehara K.

Arthritis Rheum. 1993 Aug;36(8):1137-41.

PMID:
8343189
14.

"Borrelia-associated early-onset morphea": a particular type of scleroderma in childhood and adolescence with high titer antinuclear antibodies? Results of a cohort analysis and presentation of three cases.

Prinz JC, Kutasi Z, Weisenseel P, Pótó L, Battyáni Z, Ruzicka T.

J Am Acad Dermatol. 2009 Feb;60(2):248-55. doi: 10.1016/j.jaad.2008.09.023. Epub 2008 Nov 20.

PMID:
19022534
15.

Antihistone antibodies in linear scleroderma variants.

el-Azhary RA, Aponte CC, Nelson AM, Weaver AL, Homburger HA.

Int J Dermatol. 2006 Nov;45(11):1296-9.

PMID:
17076709
16.

Specific anti-nuclear antibodies in systemic sclerosis patients with and without skin involvement: an extended methodological approach.

Van Praet JT, Van Steendam K, Smith V, De Bruyne G, Mimori T, Bonroy C, Elewaut D, Deforce D, De Keyser F.

Rheumatology (Oxford). 2011 Jul;50(7):1302-9. doi: 10.1093/rheumatology/keq446. Epub 2011 Feb 17.

17.

Prevalence and characteristics of anti-single-stranded DNA antibodies in localized scleroderma. Comparison with systemic lupus erythematosus.

Ruffatti A, Peserico A, Rondinone R, Calligaro A, Del Ross T, Ghirardello A, Germino M, Todesco S.

Arch Dermatol. 1991 Aug;127(8):1180-3.

PMID:
1863075
18.

Clinical features of patients with morphea and the pansclerotic subtype: a cross-sectional study from the morphea in adults and children cohort.

Kim A, Marinkovich N, Vasquez R, Jacobe HT.

J Rheumatol. 2014 Jan;41(1):106-12. doi: 10.3899/jrheum.130029. Epub 2013 Dec 1.

PMID:
24293577
19.

Autoantibodies against matrix metalloproteinase-1 in patients with localized scleroderma.

Tomimura S, Ogawa F, Iwata Y, Komura K, Hara T, Muroi E, Takenaka M, Shimizu K, Hasegawa M, Fujimoto M, Sato S.

J Dermatol Sci. 2008 Oct;52(1):47-54. doi: 10.1016/j.jdermsci.2008.04.013. Epub 2008 Jun 18.

PMID:
18565735
20.

Anti-alpha-actinin antibodies cross-react with anti-ssDNA antibodies in active autoimmune hepatitis.

Renaudineau Y, Dalekos GN, Guéguen P, Zachou K, Youinou P.

Clin Rev Allergy Immunol. 2008 Jun;34(3):321-5. doi: 10.1007/s12016-007-8050-1.

PMID:
18197482
Items per page

Supplemental Content

Write to the Help Desk